Evaluating Preclinical Strategies for Robust Translation of T-Cell Engagers into the Clinic with Improved Safety & Activity Assessment

11:29 am - Thursday 25th June 2026

Speakers:

Sara Humphreys
Scientific Director, Quantitative Pharmacology
Amgen Inc.